These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18840733)

  • 1. Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs.
    Kyelem D; Biswas G; Bockarie MJ; Bradley MH; El-Setouhy M; Fischer PU; Henderson RH; Kazura JW; Lammie PJ; Njenga SM; Ottesen EA; Ramaiah KD; Richards FO; Weil GJ; Williams SA
    Am J Trop Med Hyg; 2008 Oct; 79(4):480-4. PubMed ID: 18840733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of lymphatic filariasis as a public health problem in Malawi.
    Chiphwanya J; Mkwanda S; Kabuluzi S; Mzilahowa T; Ngwira B; Matipula DE; Chaponda L; Ndhlova P; Katchika P; Mahebere Chirambo C; Moses P; Kumala J; Chiumia M; Barrett C; Betts H; Fahy J; Rebollo Polo M; Reimer L; Stanton MC; Thomas B; Freer S; Molyneux DH; Bockarie MJ; Mackenzie CD; Taylor MJ; Martindale S; Kelly-Hope LA
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011957. PubMed ID: 38363794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(29):989-91. PubMed ID: 21796097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs.
    Kastner RJ; Stone CM; Steinmann P; Tanner M; Tediosi F
    PLoS Negl Trop Dis; 2015; 9(10):e0004147. PubMed ID: 26451729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
    Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
    Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.
    de Souza DK; Gass K; Otchere J; Htet YM; Asiedu O; Marfo B; Biritwum NK; Boakye DA; Ahorlu CS
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008306. PubMed ID: 32407319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.
    Hooper PJ; Chu BK; Mikhailov A; Ottesen EA; Bradley M
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3333. PubMed ID: 25411843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control and elimination of lymphatic filariasis in Oceania: Prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998-2017.
    Graves PM; Joseph H; Coutts SP; Mayfield HJ; Maiava F; Ah Leong-Lui TA; Tupuimatagi Toelupe P; Toeaso Iosia V; Loau S; Pemita P; Naseri T; Thomsen R; Berg Soto A; Burkot TR; Wood P; Melrose W; Aratchige P; Capuano C; Kim SH; Ozaki M; Yajima A; Lammie PJ; Ottesen E; Hansell L; Baghirov R; Lau CL; Ichimori K
    Adv Parasitol; 2021; 114():27-73. PubMed ID: 34696844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endpoints for lymphatic filariasis programs.
    Grady CA; de Rochars MB; Direny AN; Orelus JN; Wendt J; Radday J; Mathieu E; Roberts JM; Streit TG; Addiss DG; Lammie PJ
    Emerg Infect Dis; 2007 Apr; 13(4):608-10. PubMed ID: 17553278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity?
    Kelly-Hope LA; Molyneux DH; Bockarie MJ
    Parasit Vectors; 2013 Feb; 6():39. PubMed ID: 23433078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The story of Lymphatic Filariasis elimination as a public health problem from Yemen.
    Al-Kubati AS; Al-Samie AR; Al-Kubati S; Ramzy RMR
    Acta Trop; 2020 Dec; 212():105676. PubMed ID: 32828916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vector control in the global program to eliminate lymphatic filariasis.
    Bockarie MJ; Pedersen EM; White GB; Michael E
    Annu Rev Entomol; 2009; 54():469-87. PubMed ID: 18798707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How elimination of lymphatic filariasis as a public health problem in the Kingdom of Cambodia was achieved.
    Khieu V; Or V; Tep C; Odermatt P; Tsuyuoka R; Char MC; Brady MA; Sidwell J; Yajima A; Huy R; Ramaiah KD; Muth S
    Infect Dis Poverty; 2018 Feb; 7(1):15. PubMed ID: 29463307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration.
    Modi A; Vaishnav KG; Kothiya K; Alexander N
    Infect Dis Poverty; 2021 May; 10(1):73. PubMed ID: 34006319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of a filariasis control program on Lihir Island, Papua New Guinea.
    Mitjà O; Paru R; Hays R; Griffin L; Laban N; Samson M; Bassat Q
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1286. PubMed ID: 21886851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from the Pacific programme to eliminate lymphatic filariasis: a case study of 5 countries.
    Huppatz C; Capuano C; Palmer K; Kelly PM; Durrheim DN
    BMC Infect Dis; 2009 Jun; 9():92. PubMed ID: 19523192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caring for patients in the global programme to eliminate lymphatic filariasis.
    Mackenzie CD; Mante S
    Int Health; 2020 Dec; 13(Suppl 1):S48-S54. PubMed ID: 33349884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.